New Zealand markets open in 7 hours 14 minutes

Ventyx Biosciences, Inc. (VTYX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
4.6600-0.1700 (-3.53%)
As of 10:45AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 340.51M
Enterprise value 49.42M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)1.11
Enterprise value/revenue N/A
Enterprise value/EBITDA -22.93

Trading information

Stock price history

Beta (5Y monthly) 0.47
52-week change 3-86.69%
S&P500 52-week change 328.04%
52-week high 340.5800
52-week low 31.8650
50-day moving average 35.3157
200-day moving average 311.9105

Share statistics

Avg vol (3-month) 32.39M
Avg vol (10-day) 3709.1k
Shares outstanding 570.5M
Implied shares outstanding 670.5M
Float 851.1M
% held by insiders 13.18%
% held by institutions 195.25%
Shares short (30 Apr 2024) 48.41M
Short ratio (30 Apr 2024) 47.39
Short % of float (30 Apr 2024) 413.97%
Short % of shares outstanding (30 Apr 2024) 411.93%
Shares short (prior month 28 Mar 2024) 49.22M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-35.91%
Return on equity (ttm)-56.76%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -207.01M
Net income avi to common (ttm)-192.6M
Diluted EPS (ttm)-3.2400
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)302.58M
Total cash per share (mrq)4.29
Total debt (mrq)11.49M
Total debt/equity (mrq)3.74%
Current ratio (mrq)22.00
Book value per share (mrq)4.36

Cash flow statement

Operating cash flow (ttm)-183.23M
Levered free cash flow (ttm)-109.9M